Bridging the gap between academic IP and technology commercialization.

Bridge

KensaGroup creates, launches and develops leading edge intellectual property platforms into successful technology-based businesses. KensaGroup uses a proprietary approach to identify and evaluate promising discoveries from universities and corporate research initiatives, then creates the necessary scientific, institutional, and financial bridges that lead from initial discovery to successful commercialization.

Latest News

10.18.17 - Novomer to open new innovation center in Rochester, NY...more

09.26.17 - Chobani Incubator Program selects Grainful to be a part of the Fall 2017 class...more

09.26.17 - AI-Driven discovery of novel predictors of Parkinson's disease progression by GNS Healthcare appears in Lancet Neurology ...more

06.19.17 - GNS Healthcare announces collaboration with Genentech for development of novel cancer therapies ...more

06.07.17 - Grainful closes $3.3million round of financing as Americans embrace savory oats...more

03.03.17 - Tukek Holding leads new biorefinery complex in Adana that will incorporate Novomer technology ...more

02.27.17 - Supercritical Carbon Dioxide–Based Sterilization of Decellularized Heart Valves...more

Contact

KensaGroup, LLC

2415 N. Triphammer Road

Ithaca, NY 14850

phone: 1.607.330.2307

Fax: 1.607.330.2319

info@kensagroup.com